LDL-C and TC mediate the risk of PNPLA3 inhibition on cardiovascular diseases. Zhang G, Jiang W, He F, Fu J, et al. J Clin Endocrinol Metab 2024 Apr 18:dgae264. doi: 10.1210.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhang G, Jiang W, He F, Fu J, et al. LDL-C and TC mediate the risk of PNPLA3 inhibition on cardiovascular diseases. J Clin Endocrinol Metab 2024 Apr 18:dgae264. doi: 10.1210.
PMID: 38636099